Absence of the Cell Cycle Inhibitor p27Kip1 Protein Predicts Poor Outcome in Patients With Stage I-III Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Absence of the Cell Cycle Inhibitor p27Kip1 Protein Predicts Poor Outcome in Patients With Stage I-III Colorectal Cancer

Published:1999-01 Issue:1 Volume:6 Page:19-25
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Belluco Claudio,Esposito Giovanni,Bertorelle Roberta,Del Mistro Annarosa,Fassina Ambrogio,Vieceli Giulia,Chieco-Bianchi Luigi,Nitti Donato,Lise Mario

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10434-999-0019-2.pdf

Reference25 articles.

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5?27.

2. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444?50.

3. Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:322?6.

4. Labianca R, Marsoni S, Pancera G, et al. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 1995;345:939?44.

5. Jessup JM, McGinnis LS, Steele GD Jr, et al. Colon cancer: report from the National Cancer Data Base. Cancer 1996;78:918?26.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR‐196a‐mediated downregulation of p27 kip1 protein promotes prostate cancer proliferation and relates to biochemical recurrence after radical prostatectomy;The Prostate;2020-07-06

2. Loss of p27Kip1 leads to expansion of CD4+ effector memory T cells and accelerates colitis-associated colon cancer in mice with a T cell lineage restricted deletion of Smad4;OncoImmunology;2020-01-01

3. Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target;Future Oncology;2010-12

4. Lymphangiogenesis: A new player in cancer progression;World Journal of Gastroenterology;2010

5. Colon and Rectum;AJCC Cancer Staging Handbook;2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3